Eurogentec obtained a license from Applied Biosystems to manufacture and sell dual-labeled oligonucleotide probes worldwide for use in the 5´ Nuclease process. This process is one of the key technologies driving real-time PCR assays. 


Eurogentec will be able to custom manufacture, market, and sell dual-labeled probes alone as well as in complete kits. These kits may contain dual-labeled probes, primers, and reagents packaged and sold with other components. The agreement grants limited pass-through use rights to Eurogentec’s research customers. The agreement also conveys rights to offer oligonucleotide design services for probes and primers for use in real-time PCR.

Previous articleMITOCHONDRIAL GENE DEFECTS AND DISORDERS
Next articleConfusing Choices for Doctors and Type 2 Diabetes Patients